AstraZeneca to buy PE-backed Amolyt Pharma for $1.05bn
Amolyt Pharma is a global clinical-stage biopharmaceutical company.
Amolyt Pharma is a global clinical-stage biopharmaceutical company.
Copyright PEI Media
Not for publication, email or dissemination
